Compound for modulating rlr, tlr, oas and/or oncostatin m pathways, use thereof for preparing a medicine, composition, method for modulating said pathways and method of treatment
Ana Marisa Chudzinski Tavassi, São Paulo-SP (BR); Roger Chammas, São Paulo-SP (BR); Maurício Barbugiani Goldfeder, São Paulo-SP (BR); Carlos Deocesano Pereira, São Paulo-SP (BR); Flávio Linchtenstein, São Paulo-SP (BR); Jean Gabriel De Souza, São Paulo-SP (BR); and Katia Luciano Pereira Morais, São Paulo-SP (BR)
Assigned to Instituto Butantan, São Paulo-SP (BR)
Appl. No. 17/296,090
Filed by Instituto Butantan, São Paulo-SP (BR)
PCT Filed Nov. 22, 2019, PCT No. PCT/BR2019/050502 § 371(c)(1), (2) Date Oct. 28, 2021, PCT Pub. No. WO2020/102875, PCT Pub. Date May 28, 2020.
Claims priority of application No. 102018074043-1 (BR), filed on Nov. 22, 2018.
Prior Publication US 2022/0370577 A1, Nov. 24, 2022